OBJECTIVE: The aim of our study was to assess the prognostic value of the ratio of neutrophil to lymphocyte (NLR) for patients with surgically treated endometrial cancer (EC). METHODS: We retrospectively reviewed 510 EC patients who were surgically treated between January 2010 and December 2016. We used receiver-operating characteristic (ROC) curve analysis to identify an optimal cut-off for NLR in predicting overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS). Nonparametric tests were used to determine the associations between NLR and clinicopathologic characteristics. The Kaplan-Meier method and Cox proportional-hazards regression were used for survival analysis. RESULTS: With a cut-off of 2.47, the 510 patients were divided into low NLR (NLR <2.47) and high NLR (NLR ≥2.47). Elevated NLR was associated with advanced stage (P=0.039), increased histology grade (P=0.005) and lymph node metastasis (P=0.041). Multivariable analysis suggested that NLR was an independent prognostic marker for OS (hazard ratio [HR] 4.7; 95% confidence interval [CI], 1.5-14.1; P =0.006), CSS (HR 3.6; 95% CI, 1.1-11.5; P =0.028) and DFS (HR 2.3; 95% CI, 1.0-5.2; P =0.044). CONCLUSION: NLR may be an independent prognostic indicator for OS, CSS and DFS. It could help clinicians with preoperative risk stratification and treatment strategy tailoring.
OBJECTIVE: The aim of our study was to assess the prognostic value of the ratio of neutrophil to lymphocyte (NLR) for patients with surgically treated endometrial cancer (EC). METHODS: We retrospectively reviewed 510 ECpatients who were surgically treated between January 2010 and December 2016. We used receiver-operating characteristic (ROC) curve analysis to identify an optimal cut-off for NLR in predicting overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS). Nonparametric tests were used to determine the associations between NLR and clinicopathologic characteristics. The Kaplan-Meier method and Cox proportional-hazards regression were used for survival analysis. RESULTS: With a cut-off of 2.47, the 510 patients were divided into low NLR (NLR <2.47) and high NLR (NLR ≥2.47). Elevated NLR was associated with advanced stage (P=0.039), increased histology grade (P=0.005) and lymph node metastasis (P=0.041). Multivariable analysis suggested that NLR was an independent prognostic marker for OS (hazard ratio [HR] 4.7; 95% confidence interval [CI], 1.5-14.1; P =0.006), CSS (HR 3.6; 95% CI, 1.1-11.5; P =0.028) and DFS (HR 2.3; 95% CI, 1.0-5.2; P =0.044). CONCLUSION: NLR may be an independent prognostic indicator for OS, CSS and DFS. It could help clinicians with preoperative risk stratification and treatment strategy tailoring.
Authors: Woo Jin Choi; Michelle C Cleghorn; Haiyan Jiang; Timothy D Jackson; Allan Okrainec; Fayez A Quereshy Journal: Ann Surg Oncol Date: 2015-04-22 Impact factor: 5.344
Authors: Maro H Sandel; Alisher R Dadabayev; Anand G Menon; Hans Morreau; Cornelis J M Melief; Rienk Offringa; Sjoerd H van der Burg; Connie M Janssen-van Rhijn; N Geeske Ensink; Rob A E M Tollenaar; Cornelis J H van de Velde; Peter J K Kuppen Journal: Clin Cancer Res Date: 2005-04-01 Impact factor: 12.531
Authors: Abdelhamed Haram; Michael R Boland; Michael E Kelly; Jarlath C Bolger; Ronan M Waldron; Michael J Kerin Journal: J Surg Oncol Date: 2017-01-20 Impact factor: 3.454